CERVEL NEUROTECH
Cervel Neurotech, Inc. (formerly NeoStim, Inc.) located in San Mateo, CA is a privately held medical device company that is pioneering an innovative, proprietary approach to non-invasive deep brain neuro-modulation. Cervel’s technology is a form of repetitive transcranial magnetic stimulation (rTMS) which uses magnetic fields to induce electrical currents within the brain to modulate the function of specific areas. The company was founded in 2008 by M. Bret Schneider, MD, and David J. Mishelevich, MD, PhD, and entrepreneur Michael J. Partsch, using technology licensed from Stanford Univesity. Acquired by Rio Grande Neurosciences in 2015
CERVEL NEUROTECH
Industry:
Biotechnology Health Care Medical Medical Device Neuroscience
Founded:
2008-01-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.cervel.com
Total Employee:
11+
Status:
Closed
Contact:
650-295-0820
Email Addresses:
[email protected]
Total Funding:
42.5 M USD
Technology used in webpage:
SPF Nginx DOSarrest Uniregistry
Current Advisors List
Founder
Investors List
D. E. Shaw & Co.
D. E. Shaw & Co. investment in Venture Round - Cervel Neurotech
Aberdare Ventures
Aberdare Ventures investment in Venture Round - Cervel Neurotech
Aberdare Ventures
Aberdare Ventures investment in Series A - Cervel Neurotech
Official Site Inspections
http://www.cervel.com
- Host name: 86-105-245-69.haip.transip.net
- IP address: 86.105.245.69
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
More informations about "Cervel Neurotech"
Cervel Neurotech - Crunchbase Company Profile
Cervel Neurotech, Inc. (formerly NeoStim, Inc.) located in San Mateo, CA is a privately held medical device company that is pioneering an innovative, …See details»
Cervel - Company Profile - Tracxn
Feb 8, 2025 Cervel - Non-invasive neuromodulation through transcranial magnetic stimulation to treat treatment resistant depression. Acquired by Rio Grande Neurosciences. Raised a total …See details»
Cervel Neurotech (USA) Funding: $42.5M - Medical Startups
Feb 26, 2025 Cervel Neurotech is a privately held medical device company, pioneering a non-invasive, non-pharmacologic and non-systemic treatment for psychiatric and neurologic …See details»
Cervel Neurotech: Company Overview - YouTube
Feb 12, 2014 Eric Meier, President and CEO of Cervel Neurotech, describes his company's novel therapeutics and how it could impact the millions of people suffering from d...See details»
Cervel Neurotech - VentureRadar
" Cervel Neurotech, a privately held medical device company based in Foster City, Calif., is pioneering a non-invasive, non-pharmacologic and non-systemic treatment for psychiatric and …See details»
Cervel Neurotech - Funding, Financials, Valuation & Investors
Cervel Neurotech was a medical device company developing solutions for non-invasive deep brain neuro-modulation procedures. New. Resources. Advanced Search. ... How much funding …See details»
Cervel Neurotech Inc - Company Profile and News
Cervel Neurotech Inc. develops medical devices. The Company offers non-invasive deep brain repetitive transcranial magnetic stimulation of cortical and subcortical structures for the …See details»
Cervel Neurotech - Contacts, Employees, Board Members
Organization. Cervel Neurotech . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Highlights. Number of Board Member and Advisor Profiles 2. …See details»
Cervel Neurotech, Inc. - Drug pipelines, Patents, Clinical trials
Explore Cervel Neurotech, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 2 news, and 2 literature.See details»
Cervel - Raised $23.6M Funding from 3 investors - Tracxn
Mar 20, 2025 List of Cervel's institutional investors. East West Bank, located in Los Angeles (United States), made their first investment in Cervel on Apr 22, 2013 in its Conventional Debt …See details»
Cervel Neurotech (Repetitive Transcranial Magnetic Stimulation)
Cervel Neurotech (Repetitive Transcranial Magnetic Stimulation) was acquired by Rio Grande Neurosciences. Data Transparency. Meet our data hygiene team. Discover how our experts …See details»
Cervel Neurotech - PitchBook
Cervel Neurotech General Information Description. Developer of a medical device designed to provide treatment for psychiatric and neurological illnesses. The company offers Steerable …See details»
Cervel Neurotech - Products, Competitors, Financials, Employees ...
Cervel Neurotech was founded in 2008. Where is Cervel Neurotech's headquarters? Cervel Neurotech's headquarters is located at 3698 Haven Ave, Redwood City. What is Cervel …See details»
Cervel Neurotech - VentureRadar
Cervel Neurotech, a privately held medical device company based in Foster City, Calif., is pioneering a non-invasive, non-pharmacologic and non-systemic treatment for psychiatric and …See details»
Cervel Neurotech snags $14.1M for anti-depression device
Apr 23, 2013 As more and more data supports brain stimulation therapy to treat pain and depression, Cervel Neurotech has hauled in $14.1 million in venture funding to develop its …See details»
AbbVie Completes Acquisition of Cerevel Therapeutics
Cerevel’s clinical-stage assets complement AbbVie’s emerging neuroscience pipeline and leading on-market brands in psychiatry, migraine and Parkinson’s disease …See details»
Cervelio - Crunchbase Company Profile & Funding
Organization. Cervelio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Also Known As Cervel.io; Company Type For Profit; Contact Email …See details»
Cerevel Therapeutics - Wikipedia
Cerevel's tagline mission statement is to "unravel the mysteries of the brain" to treat neurological disease. [19] Scientifically, its approach to therapy development focuses on understanding the …See details»
The Official Cervélo Online Store
Get small parts for your road, triathlon, CX, or gravel bike. Shop now and order directly from Cervélo. We design and engineer the world's fastest bikes.See details»
Cerevel Therapeutics - Crunchbase Company Profile & Funding
Cerevel Therapeutics may be growing as evidenced by the acquisition by AbbVie in an all-cash deal valued at $8.7 billion, which is a significant financial transaction indicating a high valuation …See details»